Zobrazeno 1 - 10
of 17
pro vyhledávání: '"E. A. Glubokova"'
Autor:
N. P. Kartashova, A. V. Ivanina, E. A. Glubokova, I. N. Falynskova, A. A. Poromov, I. A. Leneva
Publikováno v:
Антибиотики и Химиотерапия, Vol 67, Iss 9-10, Pp 35-41 (2022)
Interferons (IFN) have antiviral activity against many viruses, including SARS-CoV-2. A combination of IFN-a2b and the antioxidant taurine is widely used in the Russian Federation, and its antiviral activity has not been studied before. The aim of th
Externí odkaz:
https://doaj.org/article/5e1f33ca858a4d47b1e1a1acaae907b6
Autor:
I. A. Leneva, I. N. Falynskova, N. P. Kartashova, E. A. Glubokova, A. V. Poddubikov, O. A. Svitich
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 97, Iss 6, Pp 564-577 (2021)
Introduction. Pneumonia often occurs secondary to influenza infection and accounts for a large proportion of the morbidity and mortality associated with seasonal and pandemic influenza outbreaks. We previously have shown that vaccination with Virus-l
Externí odkaz:
https://doaj.org/article/b5e35603be02458b821f44099ad6c19c
Autor:
I. N. Falynskova, A. Yu. Egorov, A. V. Poddubikov, N. O. Vartanova, N. P. Kartashova, E. A. Glubokova, V. A. Mkhitarov, D. S. Dzhalilova, O. V. Makarova, I. A. Leneva
Publikováno v:
Вопросы вирусологии, Vol 65, Iss 3, Pp 150-158 (2020)
Introduction. Influenza is a severe viral disease, a frequent complication of which is a secondary bacterial pneumonia. Influenza vaccines prevent secondary bacterial complications. Virus-like particles are one of the promising areas for the developm
Externí odkaz:
https://doaj.org/article/336733994bfa484081ce9e07daabbd5a
Autor:
I. N. Falynskova, I. A. Lenyova, O. V. Makarova, N. R. Makhmudova, E. A. Glubokova, N. P. Kartashova, V. A. Mkhitarov, D. Sh. Dzhalilova
Publikováno v:
Антибиотики и Химиотерапия, Vol 62, Iss 11-12, Pp 21-28 (2020)
Riamilovir (Triazavirin®) Is an original Russian preparation of the azoloazine family, an analogue of the purine nucleoside (guanosine), it belongs to inhibitors of the synthesis of viral RNAs and replicators of genomic fragments. The drug has a wid
Externí odkaz:
https://doaj.org/article/2a8148f6a0ab4d1698794436736e2626
Autor:
A. A. Poromov, N. R. Makhmudova, I. N. Falynskova, E. A. Glubokova, N. P. Kartashova, I. T. Fedyakina, O. A. Svitich, I. A. Leneva
Publikováno v:
Медицинская иммунология, Vol 22, Iss 1, Pp 99-110 (2020)
Secondary bacterial infections after influenza virus infection further increase morbidity and mortality due to influenza. Despite of seasonal influenza vaccination, antiviral drugs and antibiotics are widely used in viral/bacterial pneumonia therapy.
Externí odkaz:
https://doaj.org/article/de8b54f6a44a4adf9274be541b89aa58
Autor:
I. A. Leneva, A. Yu. Egorov, I. N. Falynskova, N. R. Маkhmudоvа, N. P. Kartashova, E. A. Glubokova, N. O. Vartanova, A. V. Poddubikov
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 1, Iss 1, Pp 68-74 (2019)
Aim. In this study we developed and characterized a mouse model of secondary S. aureus and S. pneumoniae pneumonia following influenza virus infection with H1N1 pandemic and laboratory strains and their reassortment. Materials and methods. BALB/с mi
Externí odkaz:
https://doaj.org/article/e296b1740a0f419499595bd8e24172f2
Publikováno v:
Nauchno-prakticheskii zhurnal «Patogenez». :55-63
Целью исследования была оценка противовирусной активности экспериментальных образцов сверхвысоких разведений антител к различным ми
Autor:
D V, Glazkova, E V, Bogoslovskaya, F A, Urusov, N P, Kartashova, E A, Glubokova, A V, Gracheva, E B, Faizuloev, G V, Trunova, V A, Khokhlova, O A, Bezborodova, A A, Pankratov, I A, Leneva, G A, Shipulin
Publikováno v:
Molekuliarnaia biologiia. 56(5)
One of the most important steps in the development of drugs and vaccines against a new coronavirus infection is their testing on a relevant animal model. The laboratory mouse, with well-studied immunology, is the preferred mammalian model in experime
Autor:
S. M. Andreev, A. A. Lushnikova, E. G. Glubokova, Alexandr Vladislavovich Kostarev, D. A. Ponkratova, A. V. Onyan
Publikováno v:
Uspehi Molekulârnoj Onkologii, Vol 5, Iss 3, Pp 59-64 (2018)
Background. Chaperone proteins nucleolin (NCL, or C23) and nucleophosmin (NPM, or B23) regulate key cell functions. The most tumors are characterized by over-expression of these proteins, especially in cell nuclei and on the сell surface, as NCL. Di
Autor:
D. V. Glazkova, E. V. Bogoslovskaya, F. A. Urusov, N. P. Kartashova, E. A. Glubokova, A. V. Gracheva, E. B. Faizuloev, G. V. Trunova, V. A. Khokhlova, O. A. Bezborodova, A. A. Pankratov, I. A. Leneva, G. A. Shipulin
Publikováno v:
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::445ad94c5277f402950ad0353a84db48
http://www.scopus.com/inward/record.url?eid=2-s2.0-85138645459&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-85138645459&partnerID=MN8TOARS